AGIO

Quote

Short

News

Articles

Message Board

Agios Pharmaceuticals Inc. (NASDAQ : AGIO ) News

Agios Pharmaceuticals Inc. (NASDAQ: AGIO) News Releases

AGIO News Releases

June 01, 2026 04:24:07 pm

SeekingAlpha

Agios Pharmaceuticals, Inc. (AGIO) Discusses Global License Agreement for Cevidoplenib and Strategic Expansion in Rare Hematology Transcript

June 01, 2026 05:00:00 am

GlobeNewswire

Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib

May 29, 2026 04:11:01 pm

SeekingAlpha

Agios: 'Sell' On Tebapivat Setback LR-MDS And Competitive PK Activator Drug Class

May 29, 2026 07:53:41 am

SeekingAlpha

Agios to discontinue candidate for myelodysplastic syndromes

May 29, 2026 07:00:00 am

GlobeNewswire

Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes

May 22, 2026 10:18:00 am

Business Wire

Avanzanite Bioscience's Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia

May 22, 2026 09:15:00 am

GlobeNewswire

Agios' PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia

May 12, 2026 09:31:00 am

GlobeNewswire

Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

May 12, 2026 09:30:00 am

GlobeNewswire

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

May 02, 2026 08:15:00 am

Motley Fool

Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026)

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account